Bayer’s dilemma
► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs
German healthcare group Bayer has made a €2bn bid for Norway's Algeta, hoping to gain full...
Iran deal and oil
► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs
Crude oil prices initially eased on news of the nuclear deal in Iran but have since...
Raising awareness about child cancer
► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs
Korle-Bu, the government-run teaching hospital in Ghana, has a specialist child-cancer unit and employs the only...
A new route for Peugeot
► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs
Peugeot Citroën is planning the succession to its CEO by hiring former senior Renault executive Carlos...
How World Child Cancer works
► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs
This year's FT Seasonal Appeal is raising funds for the charity World Child Cancer. From the...
Calm crosses Atlantic
► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs
Calm has descended on eurozone debt markets so much so that volatility is greater across the...
Jaguar looks to land young drivers
► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs
Financial Times motor industry correspondent Henry Foy reports on the growing disillusion among young people over...
Introducing World Child Cancer
► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs
The FT has chosen World Child Cancer as its partner in the 2013 Seasonal Appeal. In...
Hybrid engines promise to shake up F1 | Business of F1
► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs
The Formula One season comes to an end this weekend with world champion Sebastian Vettel looking...
Strong sterling, flagging FTSE
► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs
Sterling is now higher against the dollar than it was at the end of 2012, yet...
